Truvada Found To Lower Risk Of HIV Infection Even In Fewer Doses
Findings surrounding the HIV pre-exposure prophylaxis medication Truvada continue to be promising! Research from a study now shows that those who took Truvada lowered their risk of HIV infection and didn't show an increase in riskier sexual habits.
The research was discussed Tuesday at the International AIDS Conference in Melbourne, Australia, and was published by the British journal Lancet Infectious Diseases.
It involves 1,600 gay men and transgender women who took part in the original study showing that daily use of Truvada lowered the risk of getting HIV.
After the study ended, they were offered the chance to keep getting the pills for free, and three-quarters of them agreed. All were studied for another 17 months.
No one who took the pills at least four days a week became infected. Even use two or three days a week lowered the risk of infection compared to taking the pills less often or not at all. Researchers could tell how often the drug was taken because they measured it in blood samples.
So even missing some doses results in a lowered risk of infection. What about the risk of other sexually transmitted diseases or infections due to potential decreased condom usage?
Some health officials had worried that taking Truvada might give a false sense of security and make men less likely to use condoms or to limit their partners. However, study participants reported no increase in these behaviors, and there was no rise in syphilis or herpes, other sexually spread diseases that might suggest risk-taking.
The study was done in the United States, South America, Africa and Thailand, and paid for by the U.S. National Institutes of Health.
The lack of a rise in cases of syphilis or herpes may mean that individuals are choosing to use Truvada in conjunction with condoms, meaning safe-sex practices aren't discarded with the use of the pill.
What's your take on the findings from the researchers, Instincters?